Anti-obesity effects of the dual-active adenosine A 2A /A 3 receptor-ligand LJ-4378.

Kyungmin KimHyeonyeong ImYeonho SonMinjae KimSushil Kumar TripathiLak Shin JeongYun-Hee Lee

Published in: International journal of obesity (2005) (2022)

These findings support the in vivo anti-obesity effects of LJ-4378, and suggest a novel therapeutic approach to combat obesity and related metabolic diseases.

Keyphrases

insulin resistance
metabolic syndrome
weight loss
high fat diet induced
type diabetes
weight gain
adipose tissue
skeletal muscle
physical activity
drug induced